University of Illinois at Chicago
Chicago, Illinois, 60612, United States
NCT Number: NCT04512365
The goal of the study is to better understand the neural mechanisms underlying the rewarding, reinforcing properties of delta-9-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, among healthy young adults.
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Early Phase 1
Chicago, Illinois, 60612, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A capsule that contains only dextrose filler administered during the first or second laboratory visit.
Other names: Dextrose
A capsule that contains 7.5 mg of THC as well as dextrose filler administered during the first or second laboratory visit.
Other names: Marinol
Time frame: First and second laboratory visits, around 90 minutes to 2 hours after drug administration. Outcome measure is change from placebo session RewP to THC session RewP.
Participants will complete the Doors task during electroencephalogram (EEG) capturing the RewP, with higher values indicating greater neural response to reward
Time frame: First and second laboratory visits, around 90 minutes to 2 hours after drug administration. Outcome measure is change from placebo session BOLD response to THC session BOLD response.
Participants will complete the Doors task during functional magnetic resonance imaging (fMRI) capturing BOLD response, with higher values indicating greater BOLD activation to reward
Time frame: First and second laboratory visit, at baseline (Time 0) and at peak drug response (90-120 minutes) after drug administration. Outcome measure is change in peak score during placebo (peak minus baseline) compared to change in peak score during THC
Participants will complete the ARCI-MBG self-report scale, with higher values reflecting more drug-induced euphoria
University of Illinois at Chicago
Other
Brain-Behavior Markers of Reward and Drug Effects in Young Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03662737
Alcohol Use Disorder, Alcohol-Related Disorders
Barcelona, Catalonia, Spain
View Trial DetailsNCT06758596
Cannabis Use, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT05521321
Cannabis Use, Chemically-Induced Disorders
Palo Alto, California, United States
View Trial DetailsNCT05345951
Adolescent Behavior, Alcohol Drinking
University Park, Pennsylvania, United States
View Trial Details